1. The Pharmaceutical Market: Canada
Published: October 2011
No. of Pages: 72
Price: $ 1040
Espicom's highly regarded world pharmaceutical market reports have been redesigned to
provide enhanced strategic intelligence in a user-friendly format. Each report provides in-
depth information, setting the pharmaceutical market in context. The reports provide:
Five-year projections for economic, demographic, health expenditure, health workforce
and pharmaceutical market indicators.
Specialised intelligence on OTCs, generics, biologics and biosimilars.
Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for
each market in the series.
A separate statistical health file, comprising health expenditure, health infrastructure,
health services and health personnel.
THE PHARMACEUTICAL MARKET: CANADA - REVIEW
The Canadian pharmaceutical market is projected to grow at a relatively fast rate between
2011 and 2016, strengthened by an increasing demand for pharmaceuticals, due to an
ageing population and a commitment to a high standard of healthcare provision. However,
due to the economic recession, public finances are set to deteriorate for the first time in a
decade, and spending constraints could affect future expenditure on healthcare.
Patented drug prices in Canada are controlled by the government and tend to be
considerably lower than in the USA. This continues to irk the branded industry, and has led
to a burgeoning parallel trade between the two countries. Canadian pharmaceutical
exports exceed US$6 billion, and this strong export performance can be attributed to
parallel trade with the USA.
Canada’s domestic drug industry is dominated by a handful of multinationals and local
generic producers. The largest local company is Apotex, one of the world’s foremost
generic producers. Local research-based companies tend to be small development stage
operations, while a number of major multinational companies have manufacturing
operations in Canada. In March 2011, Valeant completed its acquisition of PharmaSwiss for
350.0 million euros (US$437.5 million). In January 2011, Stirling announced that its
manufacturing facility in Cape Breton, which it acquired in March 2010, had been granted
an Establishment Licence, and that the company could now manufacture pharmaceuticals
at the site.
ENHANCED STRATEGIC INTELLIGENCE
Espicom's highly regarded world pharmaceutical market reports have been redesigned to
provide enhanced strategic intelligence in a user-friendly format. Each report provides in-
depth information, setting the pharmaceutical market in context. The reports provide:
Five-year projections for economic, demographic, health expenditure, health workforce
and pharmaceutical market indicators.
Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic
and demographic data from the Economist Intelligence Unit (EIU) for each market in the
series.
2. A separate statistical health file, comprising health expenditure, health infrastructure,
health services and health personnel.
The reports are updated quarterly, providing you with the latest information for a full
year. In addition, the service will keep you up to date with market and industry news on
a regular basis.
HEALTHCARE STATISTICS
A comprehensive tabula review, comprising demographics, epidemiology, health
expenditure, hospital and primary care infrastructure & services and healthcare personnel,
is additionally included.
Table of Contents
EXECUTIVE SUMMARY
Snapshot: Strategic Espicom Analysis
Snapshot: Key Data Projections
MACROENVIRONMENT
POLITICAL
ECONOMIC
Projections
LEGAL
Evergreening
Bill C-9, Generic Exports to Developing Countries
Canada Remained on the USTR’s Priority Watch List in 2010 � 9
DEMOGRAPHIC
Projections
Demographic Indicators
Births
Deaths
Infant Deaths
Life Expectancy at Birth
EPIDEMIOLOGY
DISEASE BURDEN
Leading Causes of Mortality
DISEASE PREVALENCE
Communicable Diseases
HIV/AIDS
Non-Communicable Diseases
Cancer
HEALTHCARE - ACCOMPANYING HEALTH STATISTICS
ORGANISATION
EXPENDITURE
Projections
Latest Figures
INFRASTRUCTURE
Hospital Infrastructure
SERVICES
Hospital Inpatient Services
3. WORKFORCE
Projections
Physicians
Nurses
Pharmacists
REGULATORY AFFAIRS
NATIONAL AUTHORITY
PHARMACEUTICAL REGULATION
Bill C-51
Drug Approval Process
Mutual Recognition Agreements
MARKETING REGISTRATION
PROMOTION
Advertising
PRICING & REIMBURSEMENT
PRICING
Patented Medicines
Non-patented Medicines
Provincial Formularies
REIMBURSEMENT
Drug Insurance Programmes
National Pharmaceuticals Strategy
DISTRIBUTION CHANNELS
DRUG WHOLESALING
Association of Wholesalers
CAPDM
Leading Wholesalers
Kohl & Frisch
McKesson Canada
uniPHARM Wholesale Drugs
DRUG RETAILING
Association of Community Pharmacies
CACDS
Leading Pharmacy Chains
Jean Coutu Group (PJC)
Katz Group Canada
Pharmasave Drugs
Shoppers Drug Mart/ Pharmaprix
MARKET ANALYSIS
SIZE
Projections
Historical Figures
Current Structure
Hospital Drug Expenditure
PRODUCT DEVELOPMENT
MANUFACTURING
5. COMPETITION
Trade Associations
BIOTECanada
BIOQuébec
Company Intelligence
Cangene
Therapure Biopharma
CONCLUSIONS: OPPORTUNITIES & CHALLENGES
Strategic Espicom Analysis
MACROENVIRONMENT
EPIDEMIOLOGY
HEALTHCARE
REGULATORY AFFAIRS
PRICING & REIMBURSEMENT
DISTRIBUTION CHANNELS
MARKET
COMPETITION
OTC PHARMACEUTICALS
GENERIC PHARMACEUTICALS
BIOLOGICS & BIOSIMILARS
Radar Analysis
SWOT Analysis
DIRECTORY
DISTRIBUTORS
GOVERNMENT ORGANISATIONS
HEALTHCARE ORGANISATIONS
PHARMACEUTICAL COMPANIES
Generic Companies
Biologic Companies
PHARMACY CHAINS
TRADE ORGANISATIONS
List of Tables
Espicom Analysis of the Pharmaceutical Market, 2011
Key Data Projections, 2011-2016
Political Landscape, 2011
Regional Ranking of Projected Economies, 2016
Projected Economy, 2011-2016
Regional Ranking of Projected Demographics, 2016
Projected Demographics, 2011-2016
Population by Provinces & Territories, 2007-2009 (000s)
Demographic Indicators, 2002-2009
Reported Notifiable Diseases, 2003-2006
Regional Ranking of Projected Health Expenditure, 2016
Projected Health Expenditure, 2011-2016
Health Expenditure by Sector & Type, 2009 (C$ Millions)
Hospitals & Beds, 2005-2008
6. Regional Ranking of Projected Physicians, 2016
Projected Physicians, 2011-2016
Registered Nurses by Place of Employment, 2005-2007
Number of Pharmacists by Province or Territory of Registration, 2006-2007
Number of Brand Name Pharmaceutical Applications Received, 2001-2006
Pharmaceuticals Regulatory Decisions, 2003-2006
Approved New Active Substances, 2004-2006
Average Approval Times for Brand Name Drugs, 2002-2005 (Months)
Pharmacy Distributor Members of CAPDM, 2011
Pharmacies by Type and Province & Territory, 2009
Retail Members of CACDS, 2011
Shoppers Drug Mart Financial Highlights, 2008-2009 (C$000s)
Regional Ranking of Projected Pharmaceutical Markets, 2016
Projected Pharmaceutical Market at Retail Prices, 2011-2016
Historical Pharmaceutical Market at Retail Prices, 1995-2010
Manufacturers’ Sales of Patented Drugs, 1990-2008 (C$ Billions)
Sales of Patented Drugs by Therapeutic Area, 2005-2008 (C$ Millions)
Public/Private Drug Expenditure, 1975-2008 (C$ Millions)
Prescribed Drug Expenditure by Source of Finance, 2008 (C$ Millions)
Out-of-Pocket Expenditure on Medical Care and Health Services, 2002-2008 (C$ Millions)
Drug Expenditure by Province/Territory, 2001 & 2005 (C$ Millions)
Drug Expenditure in Hospitals by Province, 2003 (C$ Millions)
Total R&D Spending and R&D to Sales Ratios, 1991-2008 (C$ Million)
Canadian Pharmaceutical Manufacturers’ Shipments, 2003-July 2009 (C$/US$ 000s)
Pharmaceutical Exports by Category, 2005-2009 (US$000s)
Pharmaceutical Exports by Country/Region, 2009 (US$000s)
Canadian Exports to the USA, 2000-2009 (US$ Millions)
Exports of Retail Medicaments to the USA by Province, 2003-2009 (US$ Millions)
Pharmaceutical Imports by Category, 2005-2009 (US$000s)
Imports of Raw Materials by Country/Region, 2009 (US$000s)
Imports of Antisera & Vaccines by Country/Region, 2009 (US$000s)
Imports of Medicaments by Country/Region, 2009 (US$000s)
Balance of Pharmaceutical Trade, 2005-2009 (US$000s)
Members of Rx&D, 2011
Top 20 OTC Product Categories in Retail Prices, 2004 (C$ Millions)
Main Self-Care Health Product Companies in Canada, 2009
Active Members of Consumer Health Products Canada, 2011
Number of Generic Pharmaceutical Applications Received, 2001-2006
Average Approval Times for Generic Drugs, 2002-2005 (Months)
Canadian Generics Prescription Drugs Market, 2003-2008 (C$ Billions/US$ Billions)
Manufacturers’ Sales of Generics, 1990-2005 (C$ Billions)
Members of CGPA, 2011
Number of Biologic Applications Received, 2001-2006
Average Approval Times for Biologics, 2002-2005 (Months)
Biotechnology Products in Canadian Company Pipelines, 2009
Cangene’s Financial Results, 2004-2009 (C$000s)
Cangene’s Financial Results for Biopharmaceutical Operations, 2007-2009 (C$000s)
Espicom Analysis of the Pharmaceutical Market, 2011
SWOT Analysis of the Pharmaceutical Market, 2011
List of Charts
Wholesale Sales of Pharmaceutical Products, 2001-2008 (C$ Millions)
Regional Comparison of Top 4 Projected Pharmaceutical Markets at Retail Prices, 2016
7. Historical Pharmaceutical Market at Retail Prices, 1995-2010
Pharmaceutical Exports, 2001-2009 (US$ Millions)
Change in Pharmaceutical Exports, 2002-2009 (%)
Pharmaceutical Exports by Country/Region, 2009 (%)
Pharmaceutical Imports, 2001-2009 (US$ Millions)
Change in Pharmaceutical Imports, 2002-2009 (%)
Imports of Pharmaceuticals by Country/Region, 2009 (%)
Pharmaceutical Balance of Trade, 2001-2009 (US$ Millions)
Radar Graph of the Pharmaceutical Market, 2011
About Us:
MarketReportsOnline is comprising of an online library of over 50,000 reports and in-depth
market research studies & analysis of over 5000 micro markets. We provide 24/7 online and
offline support to our customers. Get in touch with us for your needs of market research
reports.
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com
http://www.marketreportsonline.com